Search for: "Sanofi GmbH"
Results 61 - 72
of 72
Sort by Relevance
|
Sort by Date
16 Aug 2008, 2:43 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
18 Jul 2008, 8:34 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
15 Jul 2008, 4:57 am
The patent was opposed by several companies involved in commercializing RNA interference (RNAi), including Sanofi-Aventis Deutschland GmbH, Sirna Therapeutics, Nucleonics, Inc., Quark Biotech, and Silence Therapeutics AG. [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 Jun 2008, 4:50 am
Sanofi-Aventis Deutschland GMBH et al. 2:08-cv-00258; filed June 5, 2008 in the Eastern District of Virginia Declaratory judgment of non-infringement and invalidity of U.S. [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
22 Feb 2008, 6:00 pm
: (Securing Innovation),IP in unconventional industries: (Cairns)Global - Trade Marks / Domain Names / BrandsICANN panel questions Network Solutions on domain name frontrunning: (Ars Technica), (Out-Law),ICANN: New TLD’s policy: (Class 46), ICANN not yet ready to sever ties to US government: (IP Justice), Comments to the US government on review of joint project agreement with ICANN: (IP Justice), Domain names are bigger than trade marks: ICANN’s new consumer protection role:… [read post]
15 Jan 2008, 3:06 am
There were 140 patent cases filed in the Northern District during 2007, an 11% increase from the 126 patent cases filed in 2006. [read post]
